SCHEMBL30228138

SCHEMBL30228138

CN(Cc1ccc2c(-c3ccc(F)cc3Cl)cc(=O)oc2c1)C(=O)N1CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 1/20 0.40
▸ DPP7 Q9UHL4 1/20 0.40
▸ CA12 O43570 2/20 0.39
▸ CA9 Q16790 2/20 0.39
▸ ESR1 P03372 1/20 0.39
▸ MEN1 O00255 6/20 0.38
▸ KMT2A Q03164 6/20 0.38
▸ GRM2 Q14416 1/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MCHR1 Q99705 2/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30227998 0.89 SMN1; SMN2 (0.44) CA12CA9ESR1MEN1KMT2A
SCHEMBL31710928 0.89 SMN1; SMN2 (0.44) CA12CA9ESR1MEN1KMT2A
SCHEMBL30227990 0.86 ALDH1A1 (0.46) MEN1KMT2AL3MBTL1SMN1; SMN2KDM4E
SCHEMBL30228304 0.85 DPP4 (0.45) DPP4DPP7CA12CA9ESR1
SCHEMBL30228393 0.85 DPP4 (0.45) DPP4DPP7CA12CA9ESR1
SCHEMBL30228318 0.85 DPP4 (0.45) DPP4DPP7CA12CA9ESR1
SCHEMBL30228300 0.84 MEN1 (0.42) CA12CA9ESR1MEN1KMT2A
SCHEMBL30228487 0.83 CA12 (0.40) DPP4DPP7CA12CA9ESR1
SCHEMBL30228254 0.80 DPP4 (0.44) DPP4DPP7CA12CA9MEN1
SCHEMBL20848082 0.78 ALDH1A1 (0.54) DPP4DPP7MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023034346-A1 CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2023-03-09 — — WO disclosed
Send feedback